The Study
Beyond function: supervised exercise therapy may target inflammatory gene expression in patients with symptomatic peripheral artery disease.
This study watched what happened to 51 people after they did a special exercise program, and noticed that some inflammation markers went down. But because there was no group that didn’t do the exercise, we can’t be sure the exercise caused the drop—it might’ve just been luck or something else.
Analysis score
Maximum 72 for a cohort study.
Where the score came from
This study looked at whether a 12-week walking and exercise program reduces inflammation in the blood of people with poor leg circulation, even if their walking doesn't get better.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 532 / 100
Quality score
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Even if people didn't walk farther or get stronger, their blood showed less inflammation — suggesting exercise may calm inflammation through a separate pathway.
- 2After exercise, inflammation markers dropped: PMN-elastase by 48%, myeloperoxidase by 39%, MMP-9 by 42%, NGAL by 37%, and PAD4 by 29% (some were statistically significant).
- 3PAD4 only dropped in people who didn't improve their walking.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
VASA. Zeitschrift fur Gefasskrankheiten
Year
2025
Authors
G. Buso, Stefano Lanzi, K. Bouzourène, C. Bielmann, N. Rosenblatt-Velin, Lucia Mazzolai
Related Content
Claims (5)
In patients with symptomatic peripheral artery disease, 12 weeks of supervised exercise therapy reduces the levels of two inflammatory markers—polymorphonuclear elastase and myeloperoxidase—in blood cells, regardless of whether walking ability or muscle strength improves.
In patients with symptomatic peripheral artery disease, 12 weeks of supervised exercise therapy is associated with a 42% decrease in matrix metalloproteinase-9 mRNA levels and a 37% decrease in neutrophil gelatinase-associated lipocalin levels, though these changes were not statistically significant in unadjusted analyses.
After 12 weeks of supervised exercise, people who do not improve functionally show a 29% decrease in PAD4 mRNA levels, while those who improve functionally show no change in PAD4 mRNA levels.
In patients with symptomatic peripheral artery disease, exercise therapy that reduces inflammatory gene expression does not lead to better blood flow in the limbs, improved walking ability, or increased muscle power.
Moderate-intensity aerobic exercise lowers the activity of inflammatory genes in immune cells by altering epigenetic marks or gene transcription mechanisms.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.